Literature DB >> 3545106

Surgically treated gangrenous or perforated appendicitis. A comparison of aztreonam and clindamycin versus gentamicin and clindamycin.

T V Berne, A E Yellin, M D Appleman, M A Gill, F C Chenella, P N Heseltine.   

Abstract

A randomized, double-blinded, controlled clinical study of 84 patients with surgically treated gangrenous or perforated appendicitis was done to compare the efficacy of the combination of aztreonam, the first monobactam antibiotic, with gentamicin when either was combined with clindamycin. Fifty-six patients who were treated with aztreonam and clindamycin (A/C) and 28 patients who were treated with gentamicin and clindamycin (G/C) fulfilled criteria for evaluation. A matched historic control group of 56 G/C patients was also included for comparison. All measures of outcome, including days of fever, hospitalization, antibiotic therapy, and the incidence of antibiotic failures, were similar. It was concluded that aztreonam was as effective as gentamicin in this study and may offer some advantages with regard to toxicity and serum drug level monitoring.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3545106      PMCID: PMC1492815          DOI: 10.1097/00000658-198702000-00006

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  8 in total

1.  Bacterial flora of appendicitis in children.

Authors:  H H Stone
Journal:  J Pediatr Surg       Date:  1976-02       Impact factor: 2.545

2.  Antibiotic management of surgically treated gangrenous or perforated appendicitis. Comparison of gentamicin and clindamycin versus cefamandole versus cefoperazone.

Authors:  T V Berne; A W Yellin; M D Appleman; P N Heseltine
Journal:  Am J Surg       Date:  1982-07       Impact factor: 2.565

3.  One-dose antibiotic prophylaxis against wound infection after appendicectomy: a randomized trial of clindamycin, cefazolin sodium and a placebo.

Authors:  I A Donovan; D Ellis; D Gatehouse; G Little; R Grimley; S Armistead; M R Keighley; C J Strachan
Journal:  Br J Surg       Date:  1979-03       Impact factor: 6.939

4.  A Danish multicenter study: cefoxitin versus ampicillin + metronidazole in perforated appendicitis.

Authors: 
Journal:  Br J Surg       Date:  1984-02       Impact factor: 6.939

5.  Comparative study of aztreonam and cefamandole in the treatment of serious urinary tract infections.

Authors:  W Tsouroutsoglou; M L Sion; G A Stathopoulos; S Kapoulas; M El-Messidi; A G Paradelis
Journal:  Methods Find Exp Clin Pharmacol       Date:  1983 Jul-Aug

6.  Perforated and gangrenous appendicitis: an analysis of antibiotic failures.

Authors:  P N Heseltine; A E Yellin; M D Appleman; M A Gill; F C Chenella; J W Kern; T V Berne
Journal:  J Infect Dis       Date:  1983-08       Impact factor: 5.226

7.  The role of Pseudomonas species in patients treated with ampicillin and Sulbactam for gangrenous and perforated appendicitis.

Authors:  A E Yellin; P N Heseltine; T V Berne; M D Appleman; M A Gill; C E Riggio; F C Chenella
Journal:  Surg Gynecol Obstet       Date:  1985-10

8.  In vitro activity of azthreonam, a monobactam antibiotic.

Authors:  N V Jacobus; M C Ferreira; M Barza
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

  8 in total
  4 in total

1.  Canadian practice guidelines for surgical intra-abdominal infections.

Authors:  Anthony W Chow; Gerald A Evans; Avery B Nathens; Chad G Ball; Glen Hansen; Godfrey Km Harding; Andrew W Kirkpatrick; Karl Weiss; George G Zhanel
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

2.  The bacteriology of gangrenous and perforated appendicitis--revisited.

Authors:  R S Bennion; E J Baron; J E Thompson; J Downes; P Summanen; D A Talan; S M Finegold
Journal:  Ann Surg       Date:  1990-02       Impact factor: 12.969

Review 3.  Piperacillin/tazobactam in the treatment of polymicrobial infections.

Authors:  S L Gorbach
Journal:  Intensive Care Med       Date:  1994-07       Impact factor: 17.440

Review 4.  Are there patients with peritonitis who require empiric therapy for enterococcus?

Authors:  S Harbarth; I Uckay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-21       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.